(1)
Quality-by-Design Approach and Optimization of Risk Factors by Box-Behnken Design in Formulation Development of Aspirin and Glycine Orally Disintegrating Tablet. J. Sci. Res. 2021, 13 (3), 935-950. https://doi.org/10.3329/jsr.v13i3.51952.